QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module IX Signal Analysis and Prioritisation

Test your understanding of the concepts covered by GVP Module IX: Signal Analysis and Prioritisation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A sharp increase in reports is observed after a safety communication. What is the key analytical issue?

The increase necessarily proves that the underlying risk has increased The pattern may reflect stimulated reporting or increased awareness rather than a change in incidence The reports should be excluded because post-communication data are never valid The signal should automatically be assigned the lowest priority

Question 2 of 10 What is the operational significance of the 2025 legal changes described in the article?

Organisations may continue relying on descriptions of the former MAH EudraVigilance pilot without review The adopted GVP Module IX is no longer relevant for any signal-management activity Current legislation and EMA implementation material must be considered because the former MAH EudraVigilance pilot framework changed and GVP alignment is pending The changes remove the need for MAHs to maintain internal signal-management procedures

Question 3 of 10 When evidence sources materially disagree, what should the assessor do first?

Average the findings to create a neutral conclusion Select the source with the most favourable result Investigate differences in populations, definitions, exposure, data completeness and susceptibility to bias Discard all sources that do not support the leading hypothesis

Question 4 of 10 Which statement correctly distinguishes exposed population size from event frequency?

A large exposed population proves that the event is frequent A small exposed population means that a severe event cannot be high priority Population size affects potential public-health consequences, while event frequency concerns how often the event occurs Population size and event frequency are interchangeable measures

Question 5 of 10 Which interpretation of a high disproportionality measure is most appropriate?

It is a direct estimate of incidence in treated patients It is equivalent to a relative risk from a comparative epidemiological study It describes an unusual reporting pattern that requires clinical and contextual interpretation It proves that the medicinal product caused the reported events

Question 6 of 10 What is the primary distinction between signal validation and signal analysis?

Validation establishes that an observation warrants investigation, whereas analysis evaluates what the evidence means and what remains uncertain Validation determines the final regulatory action, whereas analysis only documents the decision Validation estimates incidence, whereas analysis confirms the reporting threshold Validation prioritises public-health impact, whereas analysis determines whether a case is serious

Question 7 of 10 What should happen when new evidence materially changes a signal's potential impact or evidential strength?

The original priority should remain unchanged for consistency The signal should be deleted and recreated as a new issue Priority and, where appropriate, the assessment plan should be reassessed and the reasons recorded Only the final regulatory authority may update the internal priority

Question 8 of 10 How should an MAH respond when a safety signal originates from the EU regulatory network rather than its own detection system?

Assume that the regulatory assessment eliminates the need for internal review Assess its implications for the product's evidence, safety profile, RMP, PSUR and other applicable processes Treat it as irrelevant unless the MAH first detects the same pattern Close all related internal signals to avoid duplication

Question 9 of 10 How should time-to-onset information be interpreted?

A compatible latency proves causality Timing is irrelevant unless an epidemiological study is available Temporal patterns can support a hypothesis when considered with clinical, biological and alternative-explanation evidence Events occurring after treatment initiation should always be attributed to treatment

Question 10 of 10 Why should a previously closed signal remain retrievable?

To ensure that closure is treated as permanent To allow new evidence to be linked to the previous assessment rather than treated as an unrelated observation To prevent any future reassessment To replace the need for ongoing monitoring

Knowledge Assessment: GVP Module IX Signal Analysis and Prioritisation

Cookie Settings